胚胎干细胞的定向心肌分化及其调控机制

胚胎干细胞是具有分化为各种类型组织细胞潜能的全能干细胞,可在体外大量扩增,细胞因子、激素、诱导剂和细胞内转录因子等可诱导和调控胚胎干细胞进行心肌细胞定向分化,这将使干细胞移植治疗心肌损伤性疾病成为可能.探讨胚胎干细胞向心肌细胞的定向分化及其调控机制,进而可在体内外调控干细胞向心肌细胞的定向分化,这将为临床应用干细胞分化新生心肌细胞以治疗心肌损伤性疾病提供理想的细胞来源和可靠的理论依据.     

胚胎干细胞向成骨、软骨细胞定向分化研究进展

骨、软骨组织工程的热点之一是寻找合适的种子细胞.胚胎干细胞因具有全能性和无限增殖的能力有望成为组织工程中的种子细胞新来源.主要介绍了胚胎干细胞定向诱导分化为成骨、软骨细胞研究所取得的进展,并展望了胚胎干细胞作为组织工程种子细胞的前景和所面临的困难.     

软骨细胞上清液诱导滑膜间充质干细胞微团培养成软骨

背景：滑膜间充质干细胞在体外具有多向分化的能力,有望成为软骨组织工程中治疗软骨缺损的种子细胞,在其向软骨细胞分化过程中,合适的生长因子起了重要作用。 目的：利用富含生长因子的软骨细胞上清液诱导滑膜间充质干细胞向软骨细胞分化,并对其鉴定。 方法：采用消化法分别获得SD大鼠滑膜间充质干细胞、软骨细胞。收集软骨细胞上清液离心、过滤冻存备用。培养滑膜间充质干细胞至第3代后离心成微团,并用软骨细胞上清液进行成软骨诱导分化,通过形态学观察、免疫组织化学法、RT-PCR检测进行鉴定。 结果与结论：滑膜间充质干细胞使用软骨细胞上清液成软骨诱导21 d后,微团可见似软骨样组织。免疫组化法进行Ⅱ型胶原鉴定,基质能被Ⅱ型胶原染色,细胞染色呈现棕黄色。RT-PCR结果显示诱导后的微团表达软骨特异性基因Ⅱ型胶原和蛋白聚糖。证实软骨细胞分泌的可溶性因子可以诱导大鼠滑膜间充质干细胞向软骨方向分化。中国组织工程研究杂志出版内容重点：干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程全文链接：     

人孤雌胚胎干细胞与正常胚胎干细胞分化能力的比较

目的 比较人类孤雌胚胎干细胞(pESCs)系与正常胚胎干细胞(nESCs)系的分化能力,探讨pESCs是否和nESCs一样具有多向分化潜能.方法 将pESCs和nESCs分别注射到重症联合免疫缺陷(SCID)小鼠体内形成畸胎瘤,瘤体组织切片和HE染色后进行组织学分析;将pESCs和nESCs体外悬浮培养形成拟胚体(EB),利用RT-PCR检测3个胚层主要器官以及滋养层细胞发育关键基因的表达;将pESCs和nESCs定向诱导分化为滋养层细胞,通过流式细胞仪测定人绒毛膜促性腺激素-β(hCG-β)阳性细胞比例以及通过酶联免疫吸附测定(ELISA)进行hCG-β的定量分析.结果 在体内生长和体外培养过程中,pESCs和nESCs均能够向3个胚层的细胞类型分化.在SCID小鼠体内可形成畸胎瘤,有神经上皮、软骨、腺上皮等3个胚层的衍生物产生;pESCs和nESCs来源的EB在体外自发分化5~21d后,均检测到3个胚层主要器官以及滋养层细胞发育关键基因的表达;pESCs定向分化为滋养细胞后,可以检测到hCG-β的表达,但其阳性细胞比例和分泌量均低于nESCs.结论 pESCs具有向3个胚层以及滋养层细胞分化的能力,但是向滋养层细胞分化的能力仍低于nESCs.     

胎盘来源间充质干细胞的体外诱导成软骨分化

背景：胎盘间充质干细胞已被证实有较强的增殖能力,且能向成骨细胞、成神经细胞、类肝样细胞等诱导分化,但对其成软骨细胞诱导分化的研究不多。 目的：在体外诱导人胎盘间充质干细胞成软骨细胞分化。 方法：体外培养人胎盘间充质干细胞并鉴定。取第3代胎盘间充质干细胞,调整细胞悬液浓度为1.6×1010 L-1,在24孔板中央分别滴5,10,15 μL细胞悬液,培养2 h(目的是形成微团);然后加入间充质干细胞培养基或软骨诱导培养基培养14 d,阿利新蓝染色,进行大体观察及倒置显微镜观察。 结果与结论：应用间充质干细胞培养基培养的对照组,细胞增殖形成大量贴壁细胞,贴壁细胞具有典型的间充质细胞形态;应用软骨诱导培养基培养后,细胞只保持微团,不继续增殖形成贴壁细胞,微团基部无贴壁细胞,随着接种细胞数量的增加,微团直径增大。说明人胎盘来源间充质干细胞具有向软骨细胞分化的能力,可作为组织工程、细胞治疗等应用的种子细胞来源。中国组织工程研究杂志出版内容重点：干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程全文链接：     

胚胎干细胞的定向心肌分化及其调控机制

胚胎干细胞是具有分化为各种类型组织细胞潜能的全能干细胞,可在体外大量扩增,细胞因子、激素、诱导剂和细胞内转录因子等可诱导和调控胚胎干细胞进行心肌细胞定向分化,这将使干细胞移植治疗心肌损伤性疾病成为可能。探讨胚胎干细胞向心肌细胞的定向分化及其调控机制,进而可在体内外调控干细胞向心肌细胞的定向分化,这将为临床应用干细胞分化新生心肌细胞以治疗心肌损伤性疾病提供理想的细胞来源和可靠的理论依据。     

肾的体外诱导和干细胞治疗研究进展

随着干细胞的研究,肾脏疾患的干细胞治疗日益受到研究者的关注。拟就肾的体外诱导发育和肾疾病干细胞治疗的研究进展作一综述。包括：体外诱导胚肾组织发育;体外诱导干细胞向肾脏细胞的分化;骨髓、成体肾和胚胎肾来源的干细胞用于肾脏疾患治疗的研究。这些研究为临床部分或全部修复肾脏损伤提供了实验依据,也为肾损伤治疗提出了新的对策。     

胰岛素样生长因子Ⅰ转染对脂肪干细胞TWEAK/Fn14信号通路的影响

背景：胰岛素样生长因子Ⅰ具有诱导间充质干细胞向软骨细胞分化的能力,通过基因转染的方式将胰岛素生长因子Ⅰ转染入脂肪干细胞或许能够更好的促进脂肪干细胞向软骨细胞分化。 目的：探讨胰岛素样生长因子Ⅰ基因对脂肪间充质干细胞体外定向成软骨分化能力以及对TWEAK/Fn14信号通路的影响。 方法：构建慢病毒载体pLVX-IGF-I-IRES-ZsGreenl基因并转染第3代人脂肪间充质干细胞,诱导细胞向软骨分化。同时将pLVX-IRES-ZsGreenl转染的脂肪间充质干细胞设为绿色荧光蛋白/脂肪间充质干细胞组,单纯脂肪间充质干细胞设为对照组。 结果与结论：与绿色荧光蛋白/脂肪间充质干细胞组和对照组相比,胰岛素样生长因子Ⅰ/脂肪间充质干细胞组细胞中TWEAK mRNA表达水平降低,而胰岛素样生长因子Ⅰ,Col2al和Sox9 mRNA的表达水平增加,Col2a1表达水平增加,基质金属蛋白酶3以及TWEAK的表达降低。提示pLVX-IGF-I-IRES-ZsGreenl慢病毒转染脂肪间充质干细胞后可获得胰岛素样生长因子Ⅰ的高效表达,且能下调细胞TWEAK基因及蛋白表达,可促进体外培养的脂肪间充质干细胞转化为软骨细胞。 中国组织工程研究杂志出版内容重点：干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程     

骨髓间充质干细胞向软骨细胞分化过程中miR130α的表达

目的诱导骨髓间充质干细胞向软骨细胞分化,初步探索miR130a在骨髓间充质干细胞向软骨细胞分化过程中的调控作用。方法体外TGF-β1诱导骨髓间充质干细胞向软骨细胞分化,免疫荧光法和免疫组化染色鉴定Ⅱ型胶原,阿辛兰染色鉴定氨基葡聚糖。用Real-time PCR法检测细胞miR130a的表达。结果骨髓间充质干细胞在TGF-β1诱导下可分化为软骨细胞。培养7 d后,诱导培养组细胞miR130a表达的水平显著低于培养前的水平(P<0.05)。结论骨髓间充质干细胞体外诱导可以分化为软骨细胞,在向软骨细胞分化的早期,miR130a表达降低伴随着软骨细胞的分化,提示与软骨形成的过程有关。     

诱导性多能干细胞体外定向诱导分化的研究进展

胚胎干细胞体外定向诱导分化的研究已成为发育生物学和细胞移植治疗学的研究热点,但伦理及免疫排斥问题一直阻碍胚胎干细胞（ES）的研究和临床应用。近两年,科学家成功地从多种成体细胞获得了诱导性多能干细胞（iPS细胞）,iPS细胞具有和胚胎干细胞相似的特性,由于其可来自自体成体细胞,因而可避开伦理及免疫排斥问题,是胚胎干细胞良好的替代材料,具有广阔的应用前景。iPS只有诱导分化为成熟的功能细胞才能用于疾病的治疗。主要介绍iPS细胞向成熟细胞分化的研究现状及目前存在的一些问题。     

Directing stem cell differentiation into the chondrogenic lineage in vitro

A major area in regenerative medicine is the application of stem cells in cartilage tissue engineering and reconstructive surgery. This requires well-defined and efficient protocols for directing the differentiation of stem cells into the chondrogenic lineage, followed by their selective purification and proliferation in vitro. The development of such protocols would reduce the likelihood of spontaneous differentiation of stem cells into divergent lineages upon transplantation, as well as reduce the risk of teratoma formation in the case of embryonic stem cells. Additionally, such protocols could provide useful in vitro models for studying chondrogenesis and cartilaginous tissue biology. The development of pharmacokinetic and cytotoxicity/genotoxicity screening tests for cartilage-related biomaterials and drugs could also utilize protocols developed for the chondrogenic differentiation of stem cells. Hence, this review critically examines the various strategies that could be used to direct the differentiation of stem cells into the chondrogenic lineage in vitro.     

Ultrastructural analysis of mouse embryonic stem cell-derived chondrocytes

Pluripotent embryonic stem (ES) cells cultivated as cellular aggregates, so called embryoid bodies (EBs), differentiate spontaneously into different cell types of all three germ layers in vitro resembling processes of cellular differentiation during embryonic development. Regarding chondrogenic differentiation, murine ES cells differentiate into progenitor cells, which form pre-cartilaginous condensations in the EB-outgrowths and express marker molecules characteristic for mesenchymal cell types such as Sox5 and Sox6. Later, mature chondrocytes appear which express collagen type II, and the collagen fibers show a typical morphology as demonstrated by electron-microscopical analysis. These mature chondrogenic cells are organized in cartilage nodules and produce large amounts of extracellular proteoglycans as revealed by staining with cupromeronic blue. Finally, cells organized in nodules express collagen type X, indicating the hypertrophic stage. In conclusion, differentiation of murine ES cells into chondrocytes proceeds from the undifferentiated stem cell via progenitor cells up to mature chondrogenic cells, which then undergo hypertrophy. Furthermore, because the ES-cell-derived chondrocytes did not express elastin, a marker for elastic cartilage tissue, we suggest the cartilage nodules to resemble hyaline cartilage tissue.     

小鼠毛囊来源间充质干细胞体外诱导成软骨的细胞标记物

背景：小鼠毛囊来源的间充质干细胞有很强的多向诱导分化能力,但少有研究关注其在诱导分化为软骨细胞过程中的细胞表面标记物。 目的：观察小鼠毛囊来源的间充质干细胞分化为软骨细胞过程中的形态、细胞表面标记物和硫酸黏多糖含量的变化。 方法：体外分离培养ICR新生小鼠皮肤干细胞,用成软骨细胞诱导液诱导培养7,14 d观察各项指标。 结果与结论：经成软骨细胞诱导液处理后,小鼠毛囊来源的间充质干细胞中CD44(+)细胞数量无明显增加, 硫酸黏多糖含量无变化,CD54(+)细胞和CD166(+)细胞则显著增加,两者硫酸黏多糖含量亦明显升高。表明小鼠毛囊来源的间充质干细胞能诱导形成软骨样细胞;CD44不能作为小鼠毛囊来源的间充质干细胞向软骨细胞分化的细胞表面标记物;CD54和CD166以及硫酸黏多糖可作为对小鼠毛囊来源的间充质干细胞向软骨细胞分化的监测指标。     

Enhanced chondrogenic differentiation of murine embryonic stem cells in hydrogels with glucosamine

Differentiation of embryonic stem (ES) cells generally occurs after formation of three-dimensional cell aggregates, known as embryoid bodies (EBs). We have previously reported that hydrogels provide EBs a supportive environment for in vitro chondrogenic differentiation and three dimensional tissue formation [Hwang NS, et al. The Effects of three dimensional culture and growth factors on the chondrogenic differentiation of murine ES cells. Stem Cells 2006;24:284–91]. In this study, we report chondrogenic differentiation of murine ES cells encapsulated in photopolymerizing poly(ethylene-glycol)-based (PEG) hydrogels in the presence of glucosamine (GlcN), an amino monosaccharide found in chitin, glycoproteins and glycosaminoglycans such as hyaluronic acid, chondroitin sulfate and heparin sulfate. We examined the growth and differentiation of encapsulated EBs in standard chondrogenic differentiation medium containing 0-, 2-, and 10-mm GlcN. Morphometric analysis and examination of gene and protein expression indicated that treatment of hydrogel cultures with 2-mm GlcN for 21 days significantly increased EB size, levels of aggrecan mRNA, and tissue-specific extracellular matrix accumulation. GlcN can induce multiple aspects of cell behavior and optimal GlcN concentrations can be beneficial for directing the differentiation and tissue formation of ES cells.     

Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering

The use of tendon-derived stem cells (TDSCs) as a cell source for musculoskeletal tissue engineering has not been compared with that of bone marrow stromal cells (BMSC). This study compared the mesenchymal stem cell (MSC) and embryonic stem cells (ESC) markers, clonogenicity, proliferative capacity, and multilineage differentiation potential of rat TDSC and BMSC in vitro. The MSC and ESC marker profiles of paired TDSC and BMSC were compared using flow cytometry and quantitative real-time polymerase chain reaction (qRT-PCR), respectively. Their clonogenicity and proliferative capacity were compared using colony-forming and 5-bromo-2'-deoxyuridine assays, respectively. The expression of tenogenic, osteogenic, and chondrogenic markers at basal state were examined using qRT-PCR. Their osteogenic, chondrogenic, and adipogenic differentiation potentials were compared using standard assays. TDSC and BMSC showed similar expression of CD90 and CD73. TDSC expressed higher levels of Oct4 than BMSC. TDSC exhibited higher clonogenicity, proliferated faster, and expressed higher tenomodulin, scleraxis, collagen 1 α 1 (Col1A1), decorin, alkaline phosphatase, Col2A1, and biglycan messenger RNA levels than BMSC. There was higher calcium nodule formation and osteogenic marker expression in TDSC than BMSC upon osteogenic induction. More chondrocyte-like cells and higher glycosaminoglycan deposition and chondrogenic marker expression were observed in TDSC than BMSC upon chondrogenic induction. There were more oil droplets and expression of an adipogenic marker in TDSC than BMSC upon adipogenic induction. TDSC expressed higher Oct4 levels, which was reported to positively regulate mesendodermal lineage differentiation, showed higher clonogenicity and proliferative capacity, and had greater tenogenic, osteogenic, chondrogenic, and adipogenic markers and differentiation potential than BMSC. TDSC might be a better cell source than BMSC for musculoskeletal tissue regeneration.     

Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells

The study of human embryonic stem cells (hESCs) can provide invaluable insights into the development of numerous human cell and tissue types in vitro. In this study, we addressed the potential of hESCs to undergo chondrogenesis and demonstrated the potential of hESC-derived embryoid bodies (EBs) to undergo a well-defined full-span chondrogenesis from chondrogenic induction to hypertrophic maturation. We compared chondrogenic differentiation of hESCs through EB direct-plating outgrowth system and EB-derived high-density micromass systems under defined serumfree chondrogenic conditions and demonstrated that cell-to-cell contact and bone morphogenetic protein 2 (BMP2) treatment enhanced chondrocyte differentiation, resulting in the formation of cartilaginous matrix rich in collagens and proteoglycans. Provision of a high-density three-dimensional (3D) microenvironment at the beginning of differentiation is critical in driving chondrogenesis because increasing EB seeding numbers in the EB-outgrowth system was unable to enhance chondrogenesis. Temporal order of chondrogenic differentiation and hypertrophic maturation indicated by the gene expression profiles of Col 1, Col 2, and Col 10, and the deposition of extracellular matrix (ECM) proteins, proteoglycans, and collagen II and X demonstrated that the in vivo progression of chondrocyte maturation is recapitulated in the hESC-derived EB model system established in this study. Furthermore, we also showed that BMP2 can influence EB differentiation to multiple cell fates, including that of extraembryonic endodermal and mesenchymal lineages in the EB-outgrowth system, but was more committed to driving the chondrogenic cell fate in the EB micromass system. Overall, our findings provide a potential 3D model system using hESCs to delineate gene function in lineage commitment and restriction of chondrogenesis during embryonic cartilage development.     

人骨髓间充质干细胞的生物学特性及向神经前体细胞分化的实验研究

目的 观察体外培养的人骨髓间充质干细胞(hMSCs)的生物学特性,并探讨使其转分化为神经前体细胞(NPCs)的方法.方法以密度梯度离心和贴壁法相结合分离成人骨髓间充质干细胞,并观察细胞形态、生长、表面标记以及成骨和成软骨及成脂肪能力的情况.选用第3代细胞进行诱导,先经胚胎干细胞培养液扩增,再用加有5-氮胞苷和曲古菌素A的神经诱导液诱导,7d后,一部分样本进行Nestin、Sox2免疫荧光染色和RT-PCR检测;另一部分样本在含有B27的神经培养液中继续培养7d,然后进行NF-L的免疫荧光检测.结果分离培养的hMSCs纯度较高,CD29、CD44的阳性率均在90%以上;具有明显的成骨、成软骨和成脂肪能力;经5-氮杂胞苷和曲古菌素A作用后能向神经前体细胞分化,免疫荧光染色及RT-PCR结果显示,诱导后的细胞能特异性表达神经前体细胞标志物Nestin和Sox2;在神经培养液中继续培养后检测神经细胞标记物NF-L,可见较多阳性细胞.结论 hMSCs可在体外进行分离培养扩增,经药物修饰后具有向神经前体细胞分化的潜能.     

Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors

The in vitro study of human bone marrow mesenchymal stromal cells (BMMSCs) has largely depended on the use of primary cultures. Although these are excellent model systems, their scarcity, heterogeneity, and limited lifespan restrict their usefulness. This has led researchers to look for other sources of MSCs, and recently, such a population of progenitor/stem cells has been found in mesodermal tissues, including bone. We therefore hypothesized that a well-studied and commercially available clonal human osteoprogenitor cell line, the fetal osteoblastic 1.19 cell line (hFOB), may have multilineage differentiation potential. We found that undifferentiated hFOB cells possess similar cell surface markers as BMMSCs and also express the embryonic stem cell-related pluripotency gene, Oct-4, as well as the neural progenitor marker nestin. hFOB cells can also undergo multilineage differentiation into the mesodermal lineages of chondrogenic and adipocytic cell types in addition to its predetermined pathway, the mature osteoblast. Moreover, as with BMMSCs, under neural-inducing conditions, hFOB cells acquire a neural-like phenotype. This human cell line has been a widely used model of normal osteoblast differentiation. Our data suggest that hFOB cells may provide for researchers an easily available, homogeneous, and consistent in vitro model for study of human mesenchymal progenitor cells.     

Stage-dependent effect of TGF-beta1 on chondrogenic differentiation of human embryonic stem cells

Transforming growth factor-beta (TGF-beta) is known to be a potent inducer of stem cell chondrogenic differentiation. Transforming growth factor-beta/activin/nodal-signaling pathway has also been shown to be involved in maintaining the pluripotency of embryonic stem cells (ESCs). In this study, the effect of TGF-beta1 in chondrogenic differentiation of ESCs was examined both with undifferentiated ESCs that bypassed classical embryoid body (EB) formation, and on 5-day EB-derived cells. The effect of TGF-beta1 was compared to cells differentiated in serum-free chondrogenic basal medium without growth factor supplement. Analysis by real-time polymerase chain reaction (PCR), type II collagen enzyme-linked immunosorbent assay, sulfated glycoaminoglycan quantification and fluorescence immunostaining demonstrated substantial chondrogenic differentiation of ESCs regardless of EB formation in the absence of the growth factor. Addition of TGF-beta1 significantly inhibited chondrogenic gene expression and collagen deposition with a more potent effect on the cells that bypassed EB formation. Our study using a TGF-beta/activin/nodal-signaling inhibitor suggested that TGF-beta inhibited early chondrogenic induction but was required at the later stage of differentiation, which was also reflected in the enhancing effect of TGF-beta1 on chondrogenic development at later time points in EB-derived cells. Analysis of the pluripotency markers demonstrated sustained Oct4 and Nanog expression in the presence of TGF-beta1 with Oct4-positive cells detected in subpopulations of the differentiated culture. Our results suggest that TGF-beta1 suppresses ESC chondrogenic induction and the degree of suppression is dependent on the differentiation-stage of the ESC. Transforming growth factor-beta signaling, however, is required for functional chondrogenic development of ESC. Our finding that TGF-beta can sustain an undifferentiated population of human ESCs within the differentiation culture suggests that caution should be exercised when using this growth factor as an ESC chondrogenic inducer and highlights the importance of a selection protocol for chondroprogenitor cells to avoid possible teratoma formation in vivo.     

小鼠间充质干细胞三系分化中SOX9与Ⅱ型胶原mRNA的定量

背景：研究表明,软骨中的主要成分Ⅱ型胶原的基因-Col2a1在软骨细胞中的表达与SOX9 的浓度呈剂量依赖正相关关系。 目的：通过成骨、成软骨、成脂肪诱导干细胞分化,分析3种分化过程及不同时期的SOX9与Ⅱ型胶原 mRNA含量的变化,探讨SOX9在不同时空分布的表达规律及与Ⅱ型胶原的相关关系。 方法：取4周龄昆明小鼠骨髓间充质细胞,体外培养得到间充质干细胞并传达至第3代,对间充质干细胞进行流式细胞仪鉴定细胞表型,共分3组每组设3个时间段,通过成骨、成软骨、成脂肪3种诱导培养液对3组细胞进行诱导,另设不进行诱导的细胞作为对照组。分别在诱导3,7,14 d后收集提取细胞的总RNA,通过RT-PCR进行SOX9与Ⅱ型胶原的mRNA定量检测,同时对诱导后的细胞进行染色、免疫荧光染色,观察其分化状态及相关统计分析。 结果与结论：第3代骨髓间充质干细胞生长良好,流式细胞仪鉴定细胞表型证实为干细胞,对诱导后细胞进行染色、免疫荧光染色结果证实细胞分化为骨、软骨、脂肪细胞。经RT-PCR检测,在3组诱导分化细胞中SOX9 mRNA含量由高到低分别是成软骨、成骨、成脂肪,Ⅱ型胶原 mRNA含量由高到低分别是成软骨、成脂肪、成骨。在成软骨分化中SOX9在3,7 d表达不断升高,14 d呈下降趋势。Ⅱ型胶原在3,7,14 d均逐渐升高。在成骨分化中SOX9 mRNA含量随着时间推移而增加,而Ⅱ型胶原则随着时间推移而不断降低。在成脂肪分化中SOX9 mRNA表达与对照组比较差异无显著性意义(P > 0.05);而Ⅱ型胶原的表达没有规律可循,时间点的延伸及检测未观察到。结果提示,SOX9在软骨分化中作用优于成骨、成脂肪组,且软骨分化中SOX9与Ⅱ型胶原存在相关性,可能在软骨分化的早期Ⅱ型胶原随着SOX9的变化而变化;且软骨分化和成骨分化过程中SOX9可能起到了一个互相协调促进平衡的关键作用。